Glioma-secreted soluble factors stimulate microglial activation: The role of interleukin-1β and tumor necrosis factor-α

Journal of Neuroimmunology

Volumn 298, Issue , 2016, Pages 165-171

  Hwang, Ji Sun ^a   Jung, Eun Hye ^a   Kwon, Mi Youn ^a   Han, Inn Oc ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

Glioma; Interleukin 1beta; Microglia; Tumor necrosis factor alpha

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOOXYGENASE 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; NITRIC OXIDE; RNA; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; CONDITIONED MEDIUM; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; NITRITE; PTGS2 PROTEIN, RAT; PYRIDINE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BV2 CELL LINE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CHEMISTRY; CONDITIONED MEDIUM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NEWBORN; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLIOMA; HUMANS; IMIDAZOLES; INFANT, NEWBORN; INTERLEUKIN-1BETA; MICE; MICROGLIA; NITRITES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84982815629     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.08.001     Document Type: Article

References (43)

1. Badie, B., Schartner, J.M., Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46:4 (2000), 957–961 discussion 961–2.
2. Balkwill, F., Mantovani, A., Inflammation and cancer: back to Virchow?. Lancet 357:9255 (2001), 539–545.
3. Bettinger, I., Thanos, S., Paulus, W., Microglia promote glioma migration. Acta Neuropathol 103:4 (2002), 351–355.
4. Charles, N.A., et al. The brain tumor microenvironment. Glia 59:8 (2011), 1169–1180.
5. Charles, N.A., et al. The brain tumor microenvironment. Glia 60:3 (2012), 502–514.
6. Daginakatte, G.C., et al. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. Cancer Res 68:24 (2008), 10358–10366.
7. Demuth, T., et al. MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. Mol Cancer Ther 6:4 (2007), 1212–1222.
8. Dziembowska, M., et al. Cross-talk between Smad and p38 MAPK signalling in transforming growth factor beta signal transduction in human glioblastoma cells. Biochem Biophys Res Commun 354:4 (2007), 1101–1106.
9. Galvao, R.P., Zong, H., Inflammation and gliomagenesis: bi-directional communication at early and late stages of tumor progression. Curr Pathobiol Rep 1:1 (2013), 19–28.
10. Goebeler, M., et al. Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood 97:1 (2001), 46–55.
11. Graber, D.J., Costine, B.A., Hickey, W.F., Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets. J Neuroinflammation, 12, 2015, 76.
12. Graeber, M.B., Scheithauer, B.W., Kreutzberg, G.W., Microglia in brain tumors. Glia 40:2 (2002), 252–259.
13. Griffin, B.D., Moynagh, P.N., Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells. J Biol Chem 281:15 (2006), 10,316–10,326.
14. Herlaar, E., Brown, Z., p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 5:10 (1999), 439–447.
15. Hussain, S.F., et al. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol 8:3 (2006), 261–279.
16. Hwang, S.Y., et al. Induction of glioma apoptosis by microglia-secreted molecules: the role of nitric oxide and cathepsin B. Biochim Biophys Acta 1793:11 (2009), 1656–1668.
17. Hwang, S.Y., et al. Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury. Glia 58:15 (2010), 1881–1892.
18. Ilyin, S.E., et al. Autoregulation of the interleukin-1 system and cytokine-cytokine interactions in primary human astrocytoma cells. Brain Res Bull 51:1 (2000), 29–34.
19. Jacobs, V.L., et al. Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol 14:2 (2012), 119–131.
20. Jatana, M., et al. Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J Neuroinflammation, 3, 2006, 12.
21. Kim, W.K., et al. TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol 172:11 (2004), 7015–7023.
22. Kim, H.S., et al. Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia. J Neuroimmunol 151:1–2 (2004), 85–93.
23. Kim, Y.J., et al. C6 glioma cell insoluble matrix components enhance interferon-gamma-stimulated inducible nitric-oxide synthase/nitric oxide production in BV2 microglial cells. J Biol Chem 283:5 (2008), 2526–2533.
24. Kim, S.U., et al. Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-kappaB-mediated iNOS induction and microglial activation. J Neuroimmunol 259:1–2 (2013), 26–36.
25. Kore, R.A., Abraham, E.C., Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells. Biochem Biophys Res Commun 453:3 (2014), 326–331.
26. Lu, D.Y., et al. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia. Br J Pharmacol 151:3 (2007), 396–405.
27. Markovic, D.S., et al. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol 64:9 (2005), 754–762.
28. Maruno, M., et al. Distribution of endogenous tumour necrosis factor alpha in gliomas. J Clin Pathol 50:7 (1997), 559–562.
29. Mir, M., et al. Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation. J Neuroimmunol 204:1–2 (2008), 101–109.
30. Radeff-Huang, J., et al. Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. J Biol Chem 282:2 (2007), 863–870.
31. Rao, N.A., et al. Pathogenic role of retinal microglia in experimental uveoretinitis. Invest Ophthalmol Vis Sci 44:1 (2003), 22–31.
32. Roggendorf, W., Strupp, S., Paulus, W., Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92:3 (1996), 288–293.
33. Ryuto, M., et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271:45 (1996), 28220–28228.
34. Schneider, J., et al. Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 77:2 (1992), 265–273.
35. Sharma, V., et al. Ras regulates interleukin-1beta-induced HIF-1alpha transcriptional activity in glioblastoma. J Mol Med (Berl) 89:2 (2011), 123–136.
36. Shen, S.C., et al. Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells. J Cell Physiol 229:12 (2014), 2015–2026.
37. Sheng, W., et al. Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA(2)-IIA expression in astrocytes and microglia. J Neuroinflammation, 8, 2011, 121.
38. Wei, J., Gabrusiewicz, K., Heimberger, A., The controversial role of microglia in malignant gliomas. Clin Dev Immunol, 2013, 2013, 285,246.
39. Yamanaka, R., et al. Cytokine gene expression on glioma cell lines and specimens. J Neurooncol 21:3 (1994), 243–247.
40. Yeh, W.L., et al. A forward loop between glioma and microglia: glioma-derived extracellular matrix-activated microglia secrete IL-18 to enhance the migration of glioma cells. J Cell Physiol 227:2 (2012), 558–568.
41. Yeung, Y.T., et al. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J Neurooncol 109:1 (2012), 35–44.
42. Yeung, Y.T., et al. Interleukins in glioblastoma pathophysiology: implications for therapy. Br J Pharmacol 168:3 (2013), 591–606.
43. Zheng, J.C., et al. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R. J Neuroimmunol 200:1–2 (2008), 100–110.